BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Alprostadil

A potent vasodilator agent that increases peripheral blood flow.

297+ PubMed studies analyzed · 50 RCTs · Evidence Score: 54

Research Domains

Alprostadil has been studied across 17 research domains including ♀♂ Sexual Health, 🔬 Inflammation, ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic. The primary research focus is ♀♂ Sexual Health with 40% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Alprostadil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dinoprostone
14 shared targets
Prostaglandin
7 shared targets
Iloprost
6 shared targets
Dinoprost
7 shared targets
Misoprostol
6 shared targets
Beclomethasone
8 shared targets
Cyproterone
6 shared targets
Betamethasone
7 shared targets
Epoprostenol
4 shared targets
Stavudine
5 shared targets
Loading evidence profile...

This evidence profile for Alprostadil is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.